Jan. 19, 2023
Carlos Medina, CRO Mexico, Central America, and Caribbean at Hasten LLC
Carlos Medina is a Medical Doctor who works with health technology professionals to help them make the best technology for patient care available across Latin America. Carlos has witnessed the many benefits and risks that come with applying technology to solve health problems and is dedicated to helping others follow the best practices available and avoid the missteps that can derail their health technology problems. He has had the privilege to work with local and international companies across most countries in Latin America, helping them to achieve multi-million sales results and establish lasting and efficient global-local collaborations. He is a Licensed Medical Doctor in Mexico City. He is working on finishing his Master's degree in Information Technology for Healthcare while leading the Medical Devices workgroup of the Mexican HealthTech Association.
WEBVTT
00:00:00.609 --> 00:00:08.679
Welcome to the Latin MedTech Leaders podcast, a conversation with MedTech leaders who have succeeded or plan to succeed in Latin America.
00:00:09.109 --> 00:00:12.279
Please subscribe on your favorite podcasting platform.
00:00:12.400 --> 00:00:15.039
Apple Podcast, Spotify, Google Podcast.
00:00:15.310 --> 00:00:17.320
Amazon Music is teacher tuning.
00:00:17.550 --> 00:00:30.359
I heard radio, Pandora, or these are Welcome to the Latin MedTech Leaders podcast, a conversation with leaders who have succeeded or plan to succeed in Latin America today.
00:00:30.361 --> 00:00:32.679
Our guest is Carlos Medina.
00:00:33.810 --> 00:00:37.880
He is the lead, uh, Mexican.
00:00:37.929 --> 00:00:46.679
He leads the Mexican team for a company who's core competency is to accelerate the entry of new products into emerging markets across the globe.
00:00:46.899 --> 00:00:53.520
The company is hosting LLC and, uh, Carlos Managers Mexico, central America, and the Caribbean.
00:00:54.280 --> 00:00:54.280
Right.
00:00:54.280 --> 00:00:55.200
Carlos.
00:00:55.200 --> 00:00:56.320
That's right on the Money.
00:00:56.320 --> 00:00:57.600
Julio, thank you for the invitation.
00:00:58.280 --> 00:00:58.479
Excellent.
00:00:58.481 --> 00:00:59.840
Carlos, it's great to have you here today.
00:00:59.841 --> 00:01:01.079
Welcome to the show.
00:01:01.479 --> 00:01:01.600
All right.
00:01:03.119 --> 00:01:03.119
So
00:01:03.359 --> 00:01:05.920
It's a pleasure having a, a chance to converse with your audience.
00:01:06.040 --> 00:01:07.280
Beautiful, beautiful.
00:01:07.840 --> 00:01:13.560
I'm, I'm, I'm very pleased to have you, you here, um, Hasting and, and, and, and me have known each other.
00:01:14.000 --> 00:01:22.640
Uh, your founder, Uzi and I have known each other for quite a while, so I'm, I'm very, um, pleased to, I'm privileged to having you today.
00:01:23.519 --> 00:01:29.040
Uh, ing is growing in Latin America, so I'm sure it's gonna be an exciting, uh, episode today,
00:01:29.519 --> 00:01:33.200
, and this, this is one more of those collaborations that we like so much.
00:01:34.239 --> 00:01:35.040
Excellent, excellent.
00:01:35.719 --> 00:01:40.599
Alright, Carlos, so let's get started with, um, your journey to Latin America.
00:01:40.750 --> 00:01:42.959
I understand that you're a medical doctor.
00:01:43.260 --> 00:01:51.319
You got involved in medical innovation with Haston, and tell us about your past and, and where you are today, how you got to where you are today.
00:01:51.950 --> 00:01:58.000
Well, it all started when I went into medical school because I went there looking to do some clinical research.
00:01:58.001 --> 00:02:02.599
I like to do complex puzzles and, uh, solve the different, uh, difficult problems.
00:02:03.140 --> 00:02:11.840
And when I went into medical school, I was fortunate enough to be one of the first generations that had full access to the internet at the national University here in Mexico City.
00:02:12.659 --> 00:02:18.360
And that blew up a whole different world of technology that we could apply to medical science.
00:02:18.889 --> 00:02:29.719
So I ended up not going into, uh, clinical research, but rather, uh, going into medical informatics ever since I, uh, finished my clinical rotations.
00:02:29.721 --> 00:02:52.000
And I've been working on that, uh, for the past 20 plus years, going through editorial projects, uh, uh, continuing medical education, medical marketing, and now I'm working with trying to, uh, make business happen and to get, uh, the information flowing across the various health networks, uh, in Latin America.
00:02:53.479 --> 00:02:53.599
All right.
00:02:53.600 --> 00:02:54.199
Very good.
00:02:54.500 --> 00:02:57.599
And, uh, I just realized that I mispronounced the name of the company.
00:02:57.629 --> 00:02:59.599
I said Hasting is Hasting.
00:03:00.039 --> 00:03:02.520
It, it really depends on which country you are at.
00:03:02.879 --> 00:03:11.400
Uh, the company in Brazilian and my Brazilian countryman, uh, com, my colleagues in Brazil, they usually call it Hasan has.
00:03:12.159 --> 00:03:12.159
Okay.
00:03:12.599 --> 00:03:25.120
Uh, it may be just my, uh, us uh, my us uh, biased creeping into the name, but, uh, I liked Haston because that brings the, the connotation of doing things faster.
00:03:25.919 --> 00:03:26.610
Very good.
00:03:26.610 --> 00:03:27.449
Yeah, I like that.
00:03:27.450 --> 00:03:28.090
I like that.
00:03:28.610 --> 00:03:28.729
All right.
00:03:28.979 --> 00:03:30.650
So the company is Brazilian, right?
00:03:30.930 --> 00:03:38.090
And we're gonna get to that in a moment, but, uh, uh, uh, we're gonna speak about, uh, the, the, the genesis of the company.
00:03:38.930 --> 00:03:46.770
Um, your founder and c e o has a very interesting, uh, story behind how he got started, uh, in this business in Brazil.
00:03:46.770 --> 00:03:49.689
Anyway, so let's talk about trench, uh, Carlos.
00:03:50.449 --> 00:03:54.930
Um, what trends do you see happening in Latin America that are relevant to our discussion today?
00:03:55.120 --> 00:03:59.289
Well, it's kind of hard to, uh, miss the elephant in the room.
00:03:59.400 --> 00:04:16.129
I mean, COVID has been throwing trends left and right, but I think it has brought, uh, into very sharp focus one of those trends, which is that most of the medical technologies take a little bit longer to get to, uh, the Latin American countries.
00:04:16.509 --> 00:04:29.528
And any efforts that we can expand to make that technology get to these countries faster is going to be beneficial for all, all the patients and the medical institutions as well.
00:04:30.180 --> 00:04:38.569
So that's the first one, trying to get, uh, medical technology to take root faster in this, uh, in these countries.
00:04:38.709 --> 00:04:54.569
But other than that, I do see a lot of efforts spent by the government and, uh, by, uh, even private companies like ours to collaborate and to build networks to accelerate the development of new technologies.
00:04:54.639 --> 00:04:58.490
I see a lot of startup clusters, uh, throughout Mexico.
00:04:58.600 --> 00:05:35.170
I've been fortunate enough to work in most of the countries in, in Latin America, and I, I see a lot of, uh, technologies being, being, being brought forth to solve the inequalities of access to the medical system, uh, which is sadly another one of those trends that, uh, that, that is, uh, deeply etched into the Latin American, uh, healthcare because, uh, you've got some very big, uh, differences between access to medical technology in the rural areas and in the cities, and even between countries.
00:05:35.860 --> 00:05:54.930
So being able to use technology, particularly information technology, to level the playing field and make sure that wherever you're at, you've got your cell phone in your hand, and you've got access to medical healthcare, that it has good quality and that can actually save you time, uh, and effort going to a hospital.
00:05:54.930 --> 00:05:58.079
I think that's another one of the big trends that we have seen right now.
00:05:59.079 --> 00:05:59.278
Excellent.
00:05:59.519 --> 00:05:59.720
Excellent.
00:05:59.939 --> 00:06:04.920
And, uh, I'm very pleased to, to to hear about these trends in Mexico.
00:06:05.959 --> 00:06:20.920
Uh, I imagine you're referring to Mexico a lot when you're talking about trends, since it's your natural market and Mexico is one of the most, is is in the top three, uh, of the most attractive markets in Latin America is one of the biggest markets, right.
00:06:20.920 --> 00:06:22.519
With Brazil and then Columbia.
00:06:23.250 --> 00:06:25.519
So, and I love Mexico, by the way.
00:06:25.800 --> 00:06:26.680
It's a, it's a beautiful country.
00:06:27.120 --> 00:06:28.360
It's a country full of opportunities.
00:06:29.399 --> 00:06:32.720
Uh, and there's so much to do in Mexico, uh, still, I,
00:06:33.160 --> 00:06:33.879
Uh, I'll trade you.
00:06:34.360 --> 00:06:37.000
Uh, I will, we'll have to do a, an exchange program.
00:06:37.000 --> 00:06:41.439
You come to Mexico, I go to Columbia and leave Columbia dearly as well, so,
00:06:41.639 --> 00:06:41.639
Yeah.
00:06:41.838 --> 00:06:41.838
Yeah.
00:06:42.120 --> 00:06:42.360
Excellent.
00:06:42.360 --> 00:06:42.879
Very good.
00:06:43.310 --> 00:06:45.399
I, I think that that's another thing.
00:06:45.401 --> 00:06:49.680
Every country has a different role to play in the big organization.
00:06:49.680 --> 00:07:06.838
You have even some much smaller, uh, countries like Costa Rica or even Republica Dominica, which have such a big place in medical device manufacturer and development that, uh, it, it really doesn't have to do with the market size.
00:07:07.120 --> 00:07:18.310
It, it needs to do, uh, it, it has a lot of, uh, a lot of, uh, investment into creating the right environment to make those make those prise fruitful.
00:07:18.699 --> 00:07:19.189
Yeah.
00:07:19.190 --> 00:07:19.629
Yeah.
00:07:19.630 --> 00:07:20.029
Yeah.
00:07:20.589 --> 00:07:22.509
It's, it's interesting that you mentioned Dominican Republic.
00:07:23.269 --> 00:07:29.430
Uh, there are a lot of early stage medical device clinical trials happening in the Dominican Republic.
00:07:30.470 --> 00:07:42.910
Not, not that much aspar, why, but, uh, I see a lot of, uh, companies going to, to the Dominican Republic, and especially because a lot of our physicians in the country, uh, get trained in the United States and go back to the Dominican Republic.
00:07:42.959 --> 00:07:46.269
So they're, they have access to their colleagues and, and all that.
00:07:46.550 --> 00:07:46.550
And
00:07:46.759 --> 00:07:47.589
So, correct.
00:07:47.689 --> 00:08:04.600
And, uh, when you couple that quality of clinicians willing to do the, the work with, uh, easy regulations that allow you to do the, do the clinical trials without sacrificing the security of the patients, that's another important part.
00:08:04.990 --> 00:08:11.519
I think that's a winning combination that a lot of other countries could, uh, could follow suit and, uh, start implementing.
00:08:11.750 --> 00:08:12.240
Yeah.
00:08:12.240 --> 00:08:12.399
Yeah.
00:08:12.519 --> 00:08:14.959
And Comfort Breeze is making some changes, right?
00:08:14.961 --> 00:08:16.560
To make it easier for clinical trials.
00:08:17.379 --> 00:08:17.800
Yes.
00:08:18.079 --> 00:08:20.920
Uh, step by step, they're going in that direction.
00:08:21.009 --> 00:08:34.720
So, uh, they're trying to fast track, uh, the clinical trials, uh, and they're also trying to, uh, uh, standardize the way that they evaluate things to be more in line with international regulations.
00:08:34.990 --> 00:08:43.440
I think that was, uh, uh, a little bit, uh, a long time, uh, incoming, but, uh, it's happening now with the new administration.
00:08:43.870 --> 00:08:44.360
Yeah.
00:08:44.360 --> 00:08:44.799
Yeah.
00:08:45.200 --> 00:08:45.320
All right.
00:08:45.389 --> 00:08:50.240
Yeah, we can talk about clinical trials in Latin America, uh, uh, for hours.
00:08:50.720 --> 00:09:00.960
Uh, that's probably a topic of another episode, but let's, let's get, um, uh, uh, in, in, let's speak in more detail about, uh, Hasting, right.
00:09:01.960 --> 00:09:06.320
Uh, and, and, uh, the origining of the company and, uh, what you guys are doing in Latin America.
00:09:07.149 --> 00:09:07.639
Yeah.
00:09:07.640 --> 00:09:18.200
Well, the company, as I said, was founded in Brazil, uh, founded by, uh, one of my former bosses, uh, Eduardo DeMelo, who has had a tremendous career.
00:09:18.308 --> 00:09:20.558
He's been in pharmaceutical companies.
00:09:20.559 --> 00:09:21.440
He's done research.
00:09:21.710 --> 00:09:27.440
He's been, uh, working in, uh, uh, clinical decision support system, which is actually where we met.
00:09:27.441 --> 00:09:32.600
We both worked that up to date, and then he left off to date and started working in other projects.
00:09:32.600 --> 00:10:08.399
And he started seeing and getting this idea of trying to do exactly what I described at the beginning, trying to get medical technology to take a route and to come to developing countries much faster than it currently was, because as I said, if, uh, if you got a great blockbuster drug or medical device, but if it won't be available in your country for two or three years after it starts being offered in the main market, that really limits the options of the patients and the doctors to provide the best care possible.
00:10:08.980 --> 00:10:17.519
And, uh, he started, he started building a network of, of collaboration throughout, uh, many countries, starting in Latin America.
00:10:17.779 --> 00:10:20.600
And then he started working with, uh, China.
00:10:20.600 --> 00:10:24.519
Now we've got affiliates in Europe, in South Africa.
00:10:24.520 --> 00:10:52.600
We're working on opening up, uh, operations in India, and we're building this collaboration network so that we can work with both medical, uh, device manufacturers and medical device distributors, as well as regulatory companies to make sure that we can actually speed things up and make those, uh, those technologies available as soon as possible, uh, in emerging countries where they're mostly needed.
00:10:53.149 --> 00:10:54.200
Sure, sure.
00:10:54.289 --> 00:11:11.240
As you correctly said, Carlos, our patients in the region have delayed access to medical innovation, and a lot of it has to do with, uh, lack of information, ignorance about Latin America and, and, and not seeing the region as a, as a, as a land of opportunity.
00:11:11.308 --> 00:11:30.200
I think there's so much to do in Latin America, and right now, uh, correct me if I'm wrong, but I think, uh, the countries like Mexico, Colombia, Chile, uh, are becoming leaders in the region, and, and they are O E C D Align, even Costa Rica, they just became an O E C D country.
00:11:30.529 --> 00:11:32.639
So these countries are maturing.
00:11:32.990 --> 00:11:40.279
They are part of the global, um, economy, and they're important players.
00:11:41.000 --> 00:11:51.399
Uh, now they're part of the Pacific Alliance, which is a very, very, uh, strong block of, of, of forward-looking countries, uh, adopting international policies, best practices.
00:11:51.539 --> 00:11:58.799
And I think, uh, uh, that's part of the, uh, of what led to this situation of delayed medical innovation availability.
00:11:59.100 --> 00:12:08.879
But the other part is that, uh, when these companies start making it big, they are obviously and naturally, uh, attracted to the large markets in the US and Europe.
00:12:09.480 --> 00:12:14.000
So they're gonna be focused on achieving as much business as they can there.
00:12:14.539 --> 00:12:27.799
And, uh, a lot of the times they don't have the resources, whether they are material or, or human resources to, to be able to focus on expansion on countries that they see a secondary markets.
00:12:28.090 --> 00:12:38.919
So we can provide them an a, an opportunity to, uh, start working on those markets without having to distract themselves or their resources for that.
00:12:39.409 --> 00:12:43.678
So I think that's a big part of what's, uh, allowed us to be successful right now.
00:12:44.558 --> 00:12:46.600
That's your, your value proposition, right?
00:12:46.600 --> 00:12:59.860
So they don't, they don't have to invest much time and money and in, in, in these markets, you guys will take care of all the, the, the, the ugly work that needs to happen, and investment and all that.
00:13:00.178 --> 00:13:00.860
It's necessary work.
00:13:01.340 --> 00:13:02.740
And, uh, we'll do it.
00:13:03.000 --> 00:13:21.139
And, uh, we'll build, uh, what we hope to be a long-term partnership with both the originators, uh, the manufacturers and the distributors with us acting as catalysts in between to make thing, to make sure that things happen and they happen faster.
00:13:21.529 --> 00:13:23.299
That's a great word, catalyst.
00:13:23.490 --> 00:13:24.139
I like that.
00:13:24.460 --> 00:13:24.539
.
00:13:25.899 --> 00:13:32.240
Alright, Carlos, I'm very, very curious to hear what you think about Nancy.
00:13:32.740 --> 00:13:39.240
And, and you and I spoke about that in our initial conversation, uh, before the recording today.
00:13:39.879 --> 00:13:41.879
Uh, and what Namsa is doing in Latin America.
00:13:41.990 --> 00:13:48.519
I understand you guys are, um, are friends with Lansa, NAMSA have a collaboration with them.
00:13:48.580 --> 00:13:50.159
Can you elaborate on that, please?
00:13:50.428 --> 00:13:51.360
Sure, of course.
00:13:51.840 --> 00:14:09.639
Uh, NAMSA, uh, for those that don't, that are not familiar with, with that, they're probably not on the regulatory, uh, uh, arena, but NSE is a very big company in the US which now has, uh, uh, presence in at least, uh, three continents.
00:14:10.360 --> 00:14:23.200
Uh, right now with, uh, they provide both consulting and, um, testing services, laboratory services, as well as, uh, clinical, uh, they act as a C R O, uh, in many countries as well.
00:14:23.201 --> 00:14:38.039
So they, they actually call themselves, uh, medical research organization and, uh, we've been working with them for, uh, quite a few years right now to make sure that we can actually provide those quality services to our customers in Latin America.
00:14:38.620 --> 00:14:47.360
And I keep seeing them grow and grow because they've been offering, uh, exactly what, what they, what is needed in the region.
00:14:48.240 --> 00:15:02.440
So, uh, for companies that are looking to solve their regulatory, uh, issues for entry in the US and in Europe, those are the two markets where they, uh, where they are focused mostly.
00:15:03.440 --> 00:15:09.679
Uh, they've got consultants for every aspect of, uh, of the product development, specifically for medical devices.
00:15:09.919 --> 00:15:15.080
They don't do pharmaceuticals and, uh, they can provide end to end coverage.
00:15:15.169 --> 00:15:18.559
So, uh, it's a very good partnership, uh, for us.
00:15:18.740 --> 00:15:22.879
And that's been the backbone of, uh, a lot of our expansion to be truthful.
00:15:23.879 --> 00:15:24.600
Excellent, excellent.
00:15:24.600 --> 00:15:27.840
And also, they just acquired, uh, clean Logics, right?
00:15:27.841 --> 00:15:31.000
And Clean Logics had a strong presence in Colombia.
00:15:31.500 --> 00:15:31.919
Yes.
00:15:31.921 --> 00:15:39.879
So they just acquired Clean Logics, that's the latest, uh, the, the, the latest, uh, acquisition that they made, but they also acquired aps.
00:15:40.500 --> 00:15:50.840
And so they've acquired three major players in the regulatory, uh, and clinical research, uh, areas, uh, just in, this is Gerald alone.
00:15:51.370 --> 00:15:54.519
So they are, they are investing heavily in growth.
00:15:55.019 --> 00:16:04.840
And, uh, that's one of the other aspects that I really like, uh, about, uh, about the organization because they, they acquire technology to expand themselves.
00:16:04.841 --> 00:16:06.000
That's the nature of the business.
00:16:06.000 --> 00:16:10.679
That's one way to grow, but they don't lose the essence of those businesses.
00:16:10.879 --> 00:16:22.440
They keep what has made those businesses great companies, and they allow them to continue operating and to provide the services they have become, uh, known for.
00:16:22.740 --> 00:16:32.159
And they do that not only with the, uh, with the companies that they acquire, they also do that with partners like Hasten because they, they know, we know the market.
00:16:32.160 --> 00:16:37.960
They know that we can provide the, the local know-how on how things should be done, and they really listen.
00:16:38.450 --> 00:16:42.519
So they're able to provide all of that information to their customers as well.
00:16:42.830 --> 00:16:43.629
Beautiful.
00:16:43.630 --> 00:16:44.070
Beautiful.
00:16:44.470 --> 00:16:44.669
Excellent.
00:16:44.899 --> 00:16:45.389
Yeah.
00:16:45.390 --> 00:16:49.190
I also understand they had another collaboration with somebody in Argentina, right?
00:16:49.429 --> 00:16:51.590
That was initial collaboration that they had in Latin America
00:16:51.980 --> 00:16:53.110
That's still going?
00:16:53.250 --> 00:16:53.669
Yes.
00:16:54.110 --> 00:17:03.029
Uh, uh, Haston, we work with them to take care of, uh, customers in, uh, most of Latin America except for the Southern Cone.
00:17:03.519 --> 00:17:06.990
So Chile, Argentina, why they handle with another company.
00:17:07.980 --> 00:17:09.430
I can't remember the name of them.
00:17:09.640 --> 00:17:11.108
If I remember, I'll let you know.
00:17:12.980 --> 00:17:17.980
Uh, but yeah, the, they, they have multiple partners and they're working, uh, with us here.
00:17:18.440 --> 00:17:23.259
And, uh, they're working with other local partners in other parts of the world as well, particularly in Asia.
00:17:24.140 --> 00:17:24.819
Excellent, excellent.
00:17:25.220 --> 00:17:25.299
All right.
00:17:25.300 --> 00:17:32.180
So Carlos, let's, um, talk about your practical experience in Mexico and elsewhere in Latin America.
00:17:32.539 --> 00:17:35.539
Um, uh, the uc relevant for the discussion today.
00:17:36.500 --> 00:17:42.259
Um, how are things going in Mexico in terms of regulatory approvals for, uh, innovative technologies?
00:17:43.740 --> 00:17:45.858
Uh, any challenges you can mention?
00:17:46.039 --> 00:17:55.240
Any, any tips, any best practices that you, you can share with us so that, uh, companies that are listening can, can learn from, from, from that?
00:17:55.430 --> 00:17:55.920
Sure.
00:17:56.650 --> 00:18:08.279
So I think that, uh, when you asked me what the situation is, uh, right now, of course, COVID has brought a lot of delays in the administrative side of the regulatory affairs.
00:18:08.640 --> 00:18:30.519
Uh, you mentioned Coffee Priest, for those that might not be, uh, as familiar with Mexico Coffee Priest is the, uh, decentralized organ from the Ministry of Health that handles all regulatory, uh, uh, issues for medical device and drug and food, uh, uh, kind of like the Mexican F D A, if you wanna look at it.
00:18:30.520 --> 00:18:33.000
I think that's the, the, the easiest way to understand it.
00:18:33.539 --> 00:18:42.720
And, uh, they started prioritizing, uh, the evaluation and approvals of technologies that were covid related, like many of, uh, of the regulatory agencies did.
00:18:42.900 --> 00:18:47.640
And right now they're working off cleaning up their backlog of, uh, submissions.
00:18:47.740 --> 00:18:53.200
And they're doing that with a very, with a, uh, well-structured program that they have.
00:18:53.200 --> 00:18:59.839
They're actually keeping us in the loop and, uh, giving us information on how that's proceeding, uh, week after week.
00:19:00.680 --> 00:19:04.519
Uh, so they're slowly but surely making, uh, making headwind there.
00:19:05.400 --> 00:19:12.240
Uh, it's still, uh, a long, uh, along, uh, response time on their part.
00:19:12.240 --> 00:19:17.000
So we're talking at a close to a year, uh, on response times.
00:19:17.529 --> 00:19:21.400
So, uh, we have a lot of medical technology that's just waiting for answers.
00:19:22.358 --> 00:19:33.960
Uh, but, uh, in the meantime, while they're doing that, uh, and dealing with the new leadership in place, they just had a change in their director, and that brought changes trickling down the line.
00:19:35.000 --> 00:19:42.759
Uh, but, uh, I think that has been a good change because, uh, they're starting to, uh, digitalize most of their processes.
00:19:42.819 --> 00:20:00.880
And with the current, we just tell, we also just had a, a digital agenda, uh, released for Mexico, which is going to bring a lot of digitalization of the processes so that, uh, things will happen faster and can be automated in many, in many of those arena.
00:20:01.200 --> 00:20:02.200
So things will get better.
00:20:03.440 --> 00:20:24.400
Uh, regarding the, the trends that you, uh, were mentioning, uh, we do, I, I have to, to bring to attention that we do have a lot of players in the medical devices and medical technology arena that have had to close because of, uh, the demands on their business.
00:20:24.740 --> 00:20:34.440
But I see another very big group of companies that have thrived, uh, as I mentioned, by using, uh, the technologies available.
00:20:34.441 --> 00:20:48.358
We've seen right now, uh, the, a lot of, uh, telemedicine companies providing, uh, video conferencing and providing secure communication with the patient so that they can be tended to, to, uh, from home.
00:20:48.618 --> 00:21:20.759
And I've seen in the past year, I think I've seen more new insurance and cooperative health plans, uh, so, uh, a lot of, uh, innovation as well in, in InsureTech, uh, to take up the demand that a lot of the major and, uh, classical health insurance companies maybe had to put a break on, on taking up, uh, health policies, because they expected a lot of expenses, uh, from Covid, which I think is natural for the, uh, for the dynamic of that business.
00:21:21.140 --> 00:21:26.358
But that meant there were a lot of people looking for, uh, other avenues to get healthcare coverage.
00:21:26.779 --> 00:21:31.240
And, uh, these other companies started to, uh, to invest and to develop them.
00:21:31.240 --> 00:21:32.920
And I think a couple of them are pretty good.
00:21:34.230 --> 00:21:34.230
Okay.
00:21:34.509 --> 00:21:34.509
Okay.
00:21:34.529 --> 00:21:39.269
And how do you see the current government and the outlook for the new government?
00:21:39.270 --> 00:21:42.589
Because the Lopez Obor right?
00:21:42.868 --> 00:21:46.349
Is the new, is the current president, how many more years does he have?
00:21:47.079 --> 00:21:54.589
He just finished his third year, three years, uh, uh, and, uh, his, he has three more to go, so he sent
00:21:54.589 --> 00:21:55.230
Three more to go.
00:21:55.250 --> 00:21:55.670
Wow.
00:21:55.720 --> 00:21:56.910
So we're in the middle of
00:21:57.190 --> 00:21:57.190
.
00:21:57.191 --> 00:21:59.150
Yeah, he's right in the middle of his presidency.
00:21:59.630 --> 00:21:59.630
Mm-hmm.
00:22:00.390 --> 00:22:23.759
Uh, one thing I like about his, uh, his administration is that he has a lot of very good ideas on how to get, uh, how to enhance and, uh, uh, make all the processes that have been held up by bureaucracy and by, um, a corruption faster and cleaner.
00:22:25.130 --> 00:22:33.420
I think he needs, uh, a little bit of work and a little to listen a little bit more to his, uh, advices on how to get those done.
00:22:34.079 --> 00:22:36.358
Those have been hit or miss for me.
00:22:37.118 --> 00:22:57.799
Uh, but I, uh, I don't want to politicize this too much, uh, but, uh, the, the part that I, that I am most excited about is this, uh, digital, uh, digitalization act that just was proclaimed last month, because that's going to bring, uh, digitalization not just to healthcare, but to every aspect of the government.
00:22:58.329 --> 00:23:16.358
So, uh, a lot of the things that you formerly needed to go to an office and maybe, uh, uh, spend a lot of time, uh, cutting red tape, those should be enhanced, uh, in the next, uh, in the next few years.
00:23:16.779 --> 00:23:23.599
And particularly on the education and the access to the internet and to online services.
00:23:24.150 --> 00:23:26.079
I think they're going to be investing heavily.
00:00:00.609 --> 00:00:08.679
00:00:09.109 --> 00:00:12.279
00:00:12.400 --> 00:00:15.039
00:00:15.310 --> 00:00:17.320
00:00:17.550 --> 00:00:30.359
00:00:30.361 --> 00:00:32.679
00:00:33.810 --> 00:00:37.880
00:00:37.929 --> 00:00:46.679
00:00:46.899 --> 00:00:53.520
00:00:54.280 --> 00:00:54.280
00:00:54.280 --> 00:00:55.200
00:00:55.200 --> 00:00:56.320
00:00:56.320 --> 00:00:57.600
00:00:58.280 --> 00:00:58.479
00:00:58.481 --> 00:00:59.840
00:00:59.841 --> 00:01:01.079
00:01:01.479 --> 00:01:01.600
00:01:03.119 --> 00:01:03.119
00:01:03.359 --> 00:01:05.920
00:01:06.040 --> 00:01:07.280
00:01:07.840 --> 00:01:13.560
00:01:14.000 --> 00:01:22.640
00:01:23.519 --> 00:01:29.040
00:01:29.519 --> 00:01:33.200
00:01:34.239 --> 00:01:35.040
00:01:35.719 --> 00:01:40.599
00:01:40.750 --> 00:01:42.959
00:01:43.260 --> 00:01:51.319
00:01:51.950 --> 00:01:58.000
00:01:58.001 --> 00:02:02.599
00:02:03.140 --> 00:02:11.840
00:02:12.659 --> 00:02:18.360
00:02:18.889 --> 00:02:29.719
00:02:29.721 --> 00:02:52.000
00:02:53.479 --> 00:02:53.599
00:02:53.600 --> 00:02:54.199
00:02:54.500 --> 00:02:57.599
00:02:57.629 --> 00:02:59.599
00:03:00.039 --> 00:03:02.520
00:03:02.879 --> 00:03:11.400
00:03:12.159 --> 00:03:12.159
00:03:12.599 --> 00:03:25.120
00:03:25.919 --> 00:03:26.610
00:03:26.610 --> 00:03:27.449
00:03:27.450 --> 00:03:28.090
00:03:28.610 --> 00:03:28.729
00:03:28.979 --> 00:03:30.650
00:03:30.930 --> 00:03:38.090
00:03:38.930 --> 00:03:46.770
00:03:46.770 --> 00:03:49.689
00:03:50.449 --> 00:03:54.930
00:03:55.120 --> 00:03:59.289
00:03:59.400 --> 00:04:16.129
00:04:16.509 --> 00:04:29.528
00:04:30.180 --> 00:04:38.569
00:04:38.709 --> 00:04:54.569
00:04:54.639 --> 00:04:58.490
00:04:58.600 --> 00:05:35.170
00:05:35.860 --> 00:05:54.930
00:05:54.930 --> 00:05:58.079
00:05:59.079 --> 00:05:59.278
00:05:59.519 --> 00:05:59.720
00:05:59.939 --> 00:06:04.920
00:06:05.959 --> 00:06:20.920
00:06:20.920 --> 00:06:22.519
00:06:23.250 --> 00:06:25.519
00:06:25.800 --> 00:06:26.680
00:06:27.120 --> 00:06:28.360
00:06:29.399 --> 00:06:32.720
00:06:33.160 --> 00:06:33.879
00:06:34.360 --> 00:06:37.000
00:06:37.000 --> 00:06:41.439
00:06:41.639 --> 00:06:41.639
00:06:41.838 --> 00:06:41.838
00:06:42.120 --> 00:06:42.360
00:06:42.360 --> 00:06:42.879
00:06:43.310 --> 00:06:45.399
00:06:45.401 --> 00:06:49.680
00:06:49.680 --> 00:07:06.838
00:07:07.120 --> 00:07:18.310
00:07:18.699 --> 00:07:19.189
00:07:19.190 --> 00:07:19.629
00:07:19.630 --> 00:07:20.029
00:07:20.589 --> 00:07:22.509
00:07:23.269 --> 00:07:29.430
00:07:30.470 --> 00:07:42.910
00:07:42.959 --> 00:07:46.269
00:07:46.550 --> 00:07:46.550
00:07:46.759 --> 00:07:47.589
00:07:47.689 --> 00:08:04.600
00:08:04.990 --> 00:08:11.519
00:08:11.750 --> 00:08:12.240
00:08:12.240 --> 00:08:12.399
00:08:12.519 --> 00:08:14.959
00:08:14.961 --> 00:08:16.560
00:08:17.379 --> 00:08:17.800
00:08:18.079 --> 00:08:20.920
00:08:21.009 --> 00:08:34.720
00:08:34.990 --> 00:08:43.440
00:08:43.870 --> 00:08:44.360
00:08:44.360 --> 00:08:44.799
00:08:45.200 --> 00:08:45.320
00:08:45.389 --> 00:08:50.240
00:08:50.720 --> 00:09:00.960
00:09:01.960 --> 00:09:06.320
00:09:07.149 --> 00:09:07.639
00:09:07.640 --> 00:09:18.200
00:09:18.308 --> 00:09:20.558
00:09:20.559 --> 00:09:21.440
00:09:21.710 --> 00:09:27.440
00:09:27.441 --> 00:09:32.600
00:09:32.600 --> 00:10:08.399
00:10:08.980 --> 00:10:17.519
00:10:17.779 --> 00:10:20.600
00:10:20.600 --> 00:10:24.519
00:10:24.520 --> 00:10:52.600
00:10:53.149 --> 00:10:54.200
00:10:54.289 --> 00:11:11.240
00:11:11.308 --> 00:11:30.200
00:11:30.529 --> 00:11:32.639
00:11:32.990 --> 00:11:40.279
00:11:41.000 --> 00:11:51.399
00:11:51.539 --> 00:11:58.799
00:11:59.100 --> 00:12:08.879
00:12:09.480 --> 00:12:14.000
00:12:14.539 --> 00:12:27.799
00:12:28.090 --> 00:12:38.919
00:12:39.409 --> 00:12:43.678
00:12:44.558 --> 00:12:46.600
00:12:46.600 --> 00:12:59.860
00:13:00.178 --> 00:13:00.860
00:13:01.340 --> 00:13:02.740
00:13:03.000 --> 00:13:21.139
00:13:21.529 --> 00:13:23.299
00:13:23.490 --> 00:13:24.139
00:13:24.460 --> 00:13:24.539
00:13:25.899 --> 00:13:32.240
00:13:32.740 --> 00:13:39.240
00:13:39.879 --> 00:13:41.879
00:13:41.990 --> 00:13:48.519
00:13:48.580 --> 00:13:50.159
00:13:50.428 --> 00:13:51.360
00:13:51.840 --> 00:14:09.639
00:14:10.360 --> 00:14:23.200
00:14:23.201 --> 00:14:38.039
00:14:38.620 --> 00:14:47.360
00:14:48.240 --> 00:15:02.440
00:15:03.440 --> 00:15:09.679
00:15:09.919 --> 00:15:15.080
00:15:15.169 --> 00:15:18.559
00:15:18.740 --> 00:15:22.879
00:15:23.879 --> 00:15:24.600
00:15:24.600 --> 00:15:27.840
00:15:27.841 --> 00:15:31.000
00:15:31.500 --> 00:15:31.919
00:15:31.921 --> 00:15:39.879
00:15:40.500 --> 00:15:50.840
00:15:51.370 --> 00:15:54.519
00:15:55.019 --> 00:16:04.840
00:16:04.841 --> 00:16:06.000
00:16:06.000 --> 00:16:10.679
00:16:10.879 --> 00:16:22.440
00:16:22.740 --> 00:16:32.159
00:16:32.160 --> 00:16:37.960
00:16:38.450 --> 00:16:42.519
00:16:42.830 --> 00:16:43.629
00:16:43.630 --> 00:16:44.070
00:16:44.470 --> 00:16:44.669
00:16:44.899 --> 00:16:45.389
00:16:45.390 --> 00:16:49.190
00:16:49.429 --> 00:16:51.590
00:16:51.980 --> 00:16:53.110
00:16:53.250 --> 00:16:53.669
00:16:54.110 --> 00:17:03.029
00:17:03.519 --> 00:17:06.990
00:17:07.980 --> 00:17:09.430
00:17:09.640 --> 00:17:11.108
00:17:12.980 --> 00:17:17.980
00:17:18.440 --> 00:17:23.259
00:17:24.140 --> 00:17:24.819
00:17:25.220 --> 00:17:25.299
00:17:25.300 --> 00:17:32.180
00:17:32.539 --> 00:17:35.539
00:17:36.500 --> 00:17:42.259
00:17:43.740 --> 00:17:45.858
00:17:46.039 --> 00:17:55.240
00:17:55.430 --> 00:17:55.920
00:17:56.650 --> 00:18:08.279
00:18:08.640 --> 00:18:30.519
00:18:30.520 --> 00:18:33.000
00:18:33.539 --> 00:18:42.720
00:18:42.900 --> 00:18:47.640
00:18:47.740 --> 00:18:53.200
00:18:53.200 --> 00:18:59.839
00:19:00.680 --> 00:19:04.519
00:19:05.400 --> 00:19:12.240
00:19:12.240 --> 00:19:17.000
00:19:17.529 --> 00:19:21.400
00:19:22.358 --> 00:19:33.960
00:19:35.000 --> 00:19:42.759
00:19:42.819 --> 00:20:00.880
00:20:01.200 --> 00:20:02.200
00:20:03.440 --> 00:20:24.400
00:20:24.740 --> 00:20:34.440
00:20:34.441 --> 00:20:48.358
00:20:48.618 --> 00:21:20.759
00:21:21.140 --> 00:21:26.358
00:21:26.779 --> 00:21:31.240
00:21:31.240 --> 00:21:32.920
00:21:34.230 --> 00:21:34.230
00:21:34.509 --> 00:21:34.509
00:21:34.529 --> 00:21:39.269
00:21:39.270 --> 00:21:42.589
00:21:42.868 --> 00:21:46.349
00:21:47.079 --> 00:21:54.589
00:21:54.589 --> 00:21:55.230
00:21:55.250 --> 00:21:55.670
00:21:55.720 --> 00:21:56.910
00:21:57.190 --> 00:21:57.190
00:21:57.191 --> 00:21:59.150
00:21:59.630 --> 00:21:59.630
00:22:00.390 --> 00:22:23.759
00:22:25.130 --> 00:22:33.420
00:22:34.079 --> 00:22:36.358
00:22:37.118 --> 00:22:57.799
00:22:58.329 --> 00:23:16.358
00:23:16.779 --> 00:23:23.599
00:23:24.150 --> 00:23:26.079